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Adherens junctions and Tight junctions comprise two modes of cell–cell adhesion that provide different functions. Both junctional complexes
are proposed to associate with the actin cytoskeleton, and formation and maturation of cell–cell contacts involves reorganization of the actin
cytoskeleton. Adherens junctions initiate cell–cell contacts, and mediate the maturation and maintenance of the contact. Adherens junctions
consist of the transmembrane protein E-cadherin, and intracellular components, p120-catenin, β-catenin and α-catenin. Tight junctions regulate
the paracellular pathway for the movement of ions and solutes in-between cells. Tight junctions consist of the transmembrane proteins occludin
and claudin, and the cytoplasmic scaffolding proteins ZO-1, -2, and -3. This review discusses the binding interactions of the most studied proteins
that occur within each of these two junctional complexes and possible modes of regulation of these interactions, and the different mechanisms that
connect and regulate interactions with the actin cytoskeleton.
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The Adherens junction (AJ) and Tight junction (TJ) provide
important adhesive contacts between neighboring epithelial cells.
Although these junctions comprise different proteins, there are
similarities in the roles of specialized transmembrane proteins in
forming extracellular adhesive contacts between cells, and
intracellular links to the actin cytoskeleton and signaling
pathways including the regulation of gene transcription.
Classical cadherins, such as E-cadherin, are the major
transmembrane protein of the Adherens junction and initiate
intercellular contacts through trans-pairing between cadherins
on opposing cells [1]. Classical cadherins also bind directly and
indirectly to many cytoplasmic proteins, particularly members
of the catenin family, which locally regulate the organization of
the actin cytoskeleton, cadherin stability and intracellular
signaling pathways that control gene transcription [2]. Forma-
tion of the Adherens junction leads to assembly of the Tight
junction, but E-cadherin is not required to maintain Tight
junction organization [3]. Surprisingly, HepG2-AJ- cells unable
to form Adherens junctions slowly form functional Tight
junctions [4]. The occludin and claudin family of transmem-
brane proteins form the core of the Tight junction and control
ion selectivity and permeability of the paracellular pathway
between adhering cells. Occludin and claudins bind to members
of the MAGUK family of cytoplasmic proteins that interact with
the actin cytoskeleton and other signaling proteins that also
localize to the nucleus [5].
Recent studies of these adhesion complexes have provided
new insights into molecular mechanisms involved in the
formation, maintenance and function of protein components.
This review will focus on the formation and interactions of these
two junctional complexes, mechanisms of regulation and
dynamics of protein interactions, and how they interact with
and regulate the actin cytoskeleton.
2. Adherens junction
The Adherens junction performs multiple functions includ-
ing initiation and stabilization of cell–cell adhesion, regulation
of the actin cytoskeleton, intracellular signaling and transcrip-
tional regulation. The core of the Adherens junction includes
interactions among transmembrane glycoproteins of the classi-
cal cadherin superfamily, such as E-cadherin, and the cateninFig. 1. Adherens junctions are comprised of the single pass transmembrane protein, E
E-cadherin on neighboring cells. The intracellular domain has two binding region
Transmembrane) The protein–protein interactions presented are limited to those invol
proteins have been shown to bind. Not drawn to scale. Information was gathered ba
cited within the text.family members including p120-catenin, β-catenin, and α-
catenin. Together, these proteins control the formation,
maintenance and function of adherens junctions.
2.1. E-cadherin
E-cadherin is a single-pass, transmembrane glycoprotein
(Fig. 1) that belongs to the classical cadherin family of Ca2+-
dependent adhesion proteins; other members of this family
include N-, P, and R-cadherin [6]. Classical cadherins have five
characteristic extracellular cadherin (EC) repeat domains. These
domains form trans-cadherin interactions between neighboring
cells and initiate weak cell–cell adhesion and formation of the
Adherens junction [7]. Binding of Ca2+ to each EC domain is
required for the correct conformational organization of the
cadherin extracellular domain [8]. Recent structural studies
indicate that trans-pairing of EC1 domains is critical for cadherin
adhesion [9]. Indeed, expression of two cadherin mutant proteins
in which the EC1 domains were swapped revealed that the correct
EC1 domain determined aggregation and sorting of specific
motor neuron pools in the spinal cord [9,10]. It remains possible,
however, that other EC domains are important since amonoclonal
antibody DECMA-1, against an epitope mapped to the EC4/EC5
region [11], blocks cell–cell adhesion [12].
The cytoplasmic domain of E-cadherin binds proteins that
regulate E-cadherin endocytosis, recycling and degradation,
intracellular signaling and gene transcription, and local control
of the actin cytoskeleton [2,7]. Upon formation of intercellular
contacts, cadherins cluster and spread laterally thereby
strengthening the contact [13–15]. Clustering of cadherins in
a maturing contact requires the cytoplasmic juxtamembrane
domain [16]. Within the cytoplasmic domain there are two
relatively well-defined catenin binding domains (CBD) en-
compassing a 94-amino acid juxtamembrane domain (JMD)
that binds p120-catenin [16], and an extended region to the
C-terminal that binds β-catenin [17] (Fig. 1).
Cadherin-mediated cell–cell adhesion is highly dynamic
enabling the reorganization and dispersal of cells, for example,
during epithelial-to-mesenchymal transition in normal develop-
ment and carcinogenesis [18]. In epithelial derived tumors, loss
of cell–cell adhesion is correlated with down-regulation of E-
cadherin as well as increased proliferation and tumor invasive-
ness [19–23]. For example, E-cadherin regulates normal cell–
cell adhesion in the mammary gland and expression of E--cadherin. The extracellular domain is proposed to form trans-interactions with
s; juxtamembrane domain (JMD) and catenin binding domain (CBD). (TM;
ved in connections with the actin cytoskeleton. The asterisks represent the region
sed on mutational analysis or co-immunoprecipitation studies; all references are
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prognosis, diagnosis, and potential therapy [21]. Lobular
carcinoma, accounting for ∼15% of breast cancer, is character-
ized by a reduction or elimination of E-cadherin expression [24–
26]. Approximately 85% of cases are associated with a loss of
heterozygocity (LOH) of the E-cadherin gene on chromosome
16q [27,28]. Ductal carcinoma, accounting for ∼80% of breast
cancer, is associated with a reduction in both E-cadherin and α-
catenin [29], moreover loss of α-catenin was associated with
advanced stages and poor patient survival [30]. Together these
observations provide strong evidence that regulation of E-
cadherin and associated protein expression and localization are
factors involved in carcinogenesis.
2.2. Catenins
E-cadherin is the core transmembrane protein of the
Adherens junction and is required for binding and localization
of a number of important cytoplasmic proteins termed catenins
that connect the cadherin complex to the actin cytoskeleton and
several signaling pathways (Fig. 2). The catenin family
comprises p120-catenin, β-catenin and α-catenin. An experi-
mentally induced decrease in E-cadherin expression by siRNA
[3] causes a delay in the correct localization of adherens
junction core proteins, α- and β-catenin, and the tight junction-
associated protein ZO-1.
2.2.1. p120-catenin
p120-catenin was first identified as a substrate for Src-
tyrosine receptor kinase [31], and later defined as a member of
the catenin family based on sequence homology to an armadillo
domain of β-catenin [32] (Fig. 2A). There are four isoforms of
p120 resulting from either post-translational modifications orFig. 2. Adherens junctions are comprised of (A) p120-catenin, (B) β-catenin, and (C)
actin cytoskeleton. Asterisks represent regions known to bind the respective protein
binding site. Not drawn to scale. Information was collected either through mutati
interactions demonstrated by co-immunoprecipitation. References are cited within thdifferent internal translation start sites [33]. p120-catenin binds
E-cadherin [34] at a highly conserved octapeptide sequence
(YDEEGGGE) [35] within the juxtamembrane domain
[16,36,37]. Mutations of the E-cadherin JMD have shown that
this domain is both necessary and sufficient for recruitment of
p120-catenin to Adherens junctions [38] (Fig. 1).
Association of p120-catenin with the JMD of E-cadherin has
been proposed to stabilize E-cadherin at the plasma membrane
during the formation of cell–cell contacts. Expression of dif-
ferent cadherin cytoplasmic domains [16] and mutation analysis
of the JMD [35,38] demonstrate the p120-catenin–E-cadherin
interaction is required for increased adhesiveness of cells.
Furthermore, siRNA-mediated knock-down [39] and competi-
tive expression of other cadherins [40–42] suggest that p120-
catenin increases the retention of the cadherin complex at the
plasma membrane. Loss of p120-catenin-induced stabilization
of E-cadherin is linked to tumor progression and invasion
[19,20]. Phosphorylation of p120-catenin increases binding
affinity to E-cadherin [43]. Binding of p120-catenin to the JMD
may prevent cadherins from being internalized and degraded
[39,41,42] or lead to the recycling of internalized cadherin back
to the plasma membrane [44]. One possible mechanism of
targeting cadherin for degradation involves Hakai, an E3-
ubiquitin ligase, which binds E-cadherin in a Src-dependent
manner [45] (Fig. 1). Expression of Hakai increased both the
ubiquitination and rate of E-cadherin endocytosis [45], but it is
not known if p120-catenin binding is involved in this degra-
dation pathway. Note, however, that loss of p120-catenin in an
E-cadherin null background has also been shown to increase
cell–cell adhesion, raising the possibility that p120-catenin
plays additional roles in modulating cell–cell adhesion [46].
p120-catenin also functions as a regulator of cell motility
through the actin cytoskeleton by interacting with Rho familyα-catenin. All three proteins interact with additional proteins known to regulate
. Numbers associated with the asterisks correspond to amino acids flanking the
onal analysis or co-immunoprecipitation. Proteins without asterisks represent
e text.
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fibroblasts [37] or MDCK cells [47] increased membrane
extensions and cell migration. These effects correlated with an
increase in activated Rac and Cdc42 [47]. In p120-catenin
knock-down experiments, invasiveness of A431 cells in a three-
dimensional matrix was reduced, while re-expression of p120-
catenin that could not be phosphorylated restored cell motility.
While migration of cells was restored, an increase in Rac activity
was not observed even though Rac activation is generally
associated with increased cell migration [48]. Differences in
p120-catenin effects on cell motility could be due to differences
in cell lines, and further studies are needed to characterize the
downstream effects of p120-catenin on Rac activity. Moreover,
p120-catenin may also regulate cell motility and invasiveness
by inhibiting RhoA activity independent of p120-catenin–
E-cadherin binding [46,47]. In vitro, p120-catenin binds
RhoA-GDP which would have the effect of sequestering
RhoA from activation by a guanine exchange factor (GEF)
[49]. The affinity of the p120-catenin–RhoA interaction is
reduced by Fyn-mediated phosphorylation of p120-catenin
(Y112), and increased by Src-dependent phosphorylation of
p120-catenin (Y117, Y228) [50]. In addition, p120-catenin
interacts with p190RhoGAP, as a downstream effect of Rac
activation, and may recruit p190RhoGAP to the plasma mem-
brane resulting in local inhibition of Rho mediated contrac-
tility and antagonizing Rac and Rho signaling [51].
2.2.2. β-catenin
Beta-catenin, which was originally identified in Drosophila
as the segment polarity protein armadillo [52,53], contains
13 repeats of a characteristic armadillo domain of 42 amino
acids that form triple α-helix [54] (Fig. 2B). Beta-catenin binds
the C-terminal cytoplasmic domain of E-cadherin (Fig. 1) in
a phospho-regulated manner [2]. Three serine residues in
the cadherin cytoplasmic domain (S684, S686, S692) are
phosphorylated by CKII and GSK-3β kinases which create
additional interactions between β-catenin and E-cadherin
resulting in a large increase in the affinity of the interaction
(∼9 pM affinity; [55,56]). In contrast, tyrosine phosphorylation
of β-catenin at Y489 or Y654 disrupts binding to cadherin, and
at Y142 binding to α-catenin is weakened [57]. The structural
basis for these effects is due to β-catenin Y654 forming a
hydrogen bond with E-cadherin Asp665, which stabilizes the
interaction of the cadherin region 2 helix with the last two
armadillo repeats of β-catenin [55]; phosphorylation of Y654
would prevent this interaction thereby eliminating binding of this
region of cadherin and sharply reducing the cadherin/β-catenin
affinity. The kinases involved in β-catenin phosphorylation have
been identified and include: Src phosphorylation at Y654 [58,59],
Abl kinase phosphorylation at Y489 [60], EGF receptor
phosphorylation of Y654 [61], and Fer kinase phosphorylation
at Y142 [43]. Recently, a detailed analysis of the thermody-
namics of the β-catenin/E-cadherin interaction proposed that the
C-terminal tail ofβ-catenin (post-armadillo domain) regulates the
binding affinity for β-catenin and its ligands [62].
While there is a great deal of information on the interaction
of β-catenin and E-cadherin, there is little demonstratingwhether β-catenin dissociates from E-cadherin (for example
during E-cadherin internalization), in part because the affinity
of this interaction is very high [55]. The regulation of cytosolic
β-catenin is critical as β-catenin can bind to the transcription
factor Tcf/Lef and mediate the transcription of a genes involved
in cell proliferation, a signaling pathway activated by Wnt [63].
It is proposed that the E-cadherin/β-catenin interaction occurs
in the endoplasmic reticulum (ER) and is required for cadherin
exit from the ER [64]. Normally cytosolic levels of β-catenin
are low due to rapid targeting of excess β-catenin to the
proteosome [65,66]. However, recent studies have identified a
role for BCL9-2, a transcription factor involved in epithelial–
mesenchymal transition, in mediating a switch between the
adhesive and transcriptional functions of β-catenin. This switch
is caused by phosphorylation of Y142 on β-catenin, which
favors BCL9-2 binding and precludes other protein–protein
interactions, and results in translocation of β-catenin to the
nucleus and induction of specific gene transcription [67].
Significantly, BCL9-2 RNAi induces an epithelial phenotype in
the colon cancer cell line SW480 and causes β-catenin to
translocate from the nucleus to the plasma membrane [67].
β-catenin binds IQGAP, fascin, and α-catenin (see also
α-catenin sub-section; Fig. 2B). The α-/β-catenin interaction
dissociates upon binding to IQGAP, an actin binding protein
activated by the small GTPases Rac1 and Cdc42 [68]. Acti-
vation of IQGAP by Rac1 or Cdc42 disrupts IQGAP binding to
β-catenin resulting in rebinding of α-catenin to β-catenin and,
hence, functional assembly of the cadherin core complex and
initiation of cell–cell adhesion. β-catenin has also been
identified by yeast 2-hybrid as a direct interaction partner of
the actin bundling protein fascin, whose binding site within β-
catenin overlaps that of E-cadherin, and therefore competes
with E-cadherin for binding β-catenin [69].
2.2.3. α-catenin
The textbook model of the adherens junction states that
α-catenin is the link between the cadherin/beta-catenin complex
and the actin cytoskeleton. Indeed, α-catenin binds and bundles
actin filaments in vitro [29] and binds to β-catenin [17]
(Fig. 2C), but a ternary complex of E-cadherin/β-catenin/
α-catenin and actin had not been tested [70]. However, recent
evidence demonstrated that this simultaneous interaction could
not be reconstituted in vitro [70].
Alpha-catenin exists in either a monomeric or homo-dimeric
state. Theβ-catenin/α-catenin binding domain and theα-catenin
homodimerization domains overlap within amino acids 57–143
on α-catenin [71], but the actin and β-catenin binding domains
on α-catenin do not (Fig. 2C). In vitro binding assays
demonstrated that monomeric α-catenin binds β-catenin, but
not actin. Conversely, homo-dimeric α-catenin binds actin
filaments but not β-catenin [70]; α-catenin homo-dimer binding
to actin also appears to compete binding of the Arp2/3 complex
to actin filaments thereby suppressing actin polymerization [72].
This allosteric switch between monomeric and dimeric states
appears to be the molecular explanation for the lack of
simultaneous binding of α-catenin to both β-catenin and actin
filaments. In vitro studies showed that dimerization of α-catenin
664 A. Hartsock, W.J. Nelson / Biochimica et Biophysica Acta 1778 (2008) 660–669occurs at a 10-fold higher concentration than that of the
monomeric pool of α-catenin in the cytoplasm of epithelial cells,
indicating that α-catenin must be locally concentrated prior to
dimerization perhaps by clustering the cadherin–catenin com-
plex during cell–cell adhesion. A dynamic crosstalk between the
α-catenin plasma membrane pool (monomeric, β-catenin
bound) the cytoplasmic pool (monomeric) and cytoskeleton
pool (dimeric, actin-bound) has been proposed where α-catenin
switches between the adherens complex and binding the actin
cytoskeleton [72].
A new model for Adherens junction connection to the
cytoskeleton has been proposed [70,72]. It is suggested that the
increase in local concentration of α-catenin at the membrane
during clustering of the cadherin–catenin complex at cell–cell
contacts provides a local increase in α-catenin concentration
sufficient to drive α-catenin dimerization in the cytoplasm.
Alpha-catenin dimers would locally inhibit Arp2/3 and thereby
the formation of branching networks of actin filaments charac-
teristic of lamellipodia of migrating cells. At the same time,
α-catenin dimers bind to and bundle existing actin filaments,
resulting in actin reorganization from branched to bundled
arrays. This model predicts that the interaction of α-catenin with
the cadherin/β-catenin complex is labile such that α-catenin can
dissociate from the cadherin complex and dimerize in the
cytoplasm. Indeed, the interaction between α- and β-catenin
may be concentration-dependent (see above) or phospho-
regulated. Two large-scale proteomic analyses identified S641
and S652/S655 as phosphorylation sites on α-catenin [73,74].
Phosphorylation of tyrosine 148 on α-catenin has been shown
to increase binding to β-catenin [75]. Further investigation into
the dynamics of different α-catenin pools is needed to verify the
physiological relevance of these different α-catenin binding
states. In addition, further studies are required to test whether
an increased local concentration of α-catenin is sufficient to
drive the switch from branched to bundled actin cables, and
whether additional factors such as kinases and phosphatases are
necessary for this switch to occur.Fig. 3. Tight Junction transmembrane proteins (A) occludin and (B) claudin, and
represent the region in which the proteins have been shown to bind with the occludin
analysis or co-immunoprecipitation. All references are cited within the text.3. Tight junctions
Tight junctions have been proposed to have two mutually
exclusive functions: a fence function which prevents the mixing
of membrane proteins between the apical and basolateral
membranes; and a gate function which controls the paracellular
passage of ions and solutes in-between cells. Tight junctions
contain two types of transmembrane proteins, occludins and
claudins, which confer these functions (Fig. 3), and associated
cytoplasmic proteins (Fig. 4) that may link tight junctions to the
actin-cytoskeleton and the adherens junction.
3.1. Transmembrane components of tight junctions
3.1.1. Occludin
Occludin is an ∼65-kDa tetraspan protein with two
extracellular loops [5,76] (Fig. 3A). There are two isoforms of
occludin that result from alternative mRNA splicing, but have
similar tissue distributions [77]. Localization of occludin to
tight junctions is regulated by phosphorylation in both epithelial
and endothelial cells [78]. Western blot analysis of occludin
reveals a range of molecular weights (62–82 kDa) that are
sensitive to alkaline phosphatase treatment. Multiple phosphor-
ylation sites have been identified on tyrosine [79], serine, and
threonine residues [78]. Non-phosphorylated occludin is
localized to both the basolateral membrane and in cytoplasmic
vesicles, whereas phosphorylated occludin is localized to tight
junctions [78]. Multiple kinase and phosphatases are proposed
to regulate occludin phosphorylation states and its localization
and function within the tight junction. The non-receptor
tyrosine kinase c-Yes co-localizes and co-immunoprecipitates
with occludin in Ras-transformed MDCK cells [80]. In addition,
when c-Yes is inhibited by CGP77675 occludin phosphoryla-
tion and tight junction localization are decreased, and trans-
epithelial resistance (TER), a measure of paracellular perme-
ability, is increased [80]. Protein kinase C (PKC) stimulated by
phorbol 12-myristate 13-acetate and 1,2 dioctanoylglycerol inproposed binding partners with corresponding binding regions. The asterisks
and claudin. Not drawn to scale. Information was gathered based on mutational
Fig. 4. ZO proteins are proposed to be a scaffolding protein that could link Tight junctions to the actin cytoskeleton through a direct interaction with actin or through
additional protein interactions. In addition, ZO proteins may link Adherens junctions to Tight junctions through protein linkages. Proteins represented are proposed for
these functions. Asterisks represent the region in which the proteins have been shown to bind with ZO protein. Numbers correspond with the amino acids on the parent
ZO protein; not drawn to scale. Information was gathered based on mutational analysis or co-immunoprecipitation. Proteins without asterisks represent interactions
demonstrated by co-immunoprecipitation but regions were not determined. All references are cited within the text.
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tion to tight junctions [81]. Incubation of C-terminal occludin
with purified PKC identified Ser 338 of occludin as a
phosphorylation site [81]. However, stimulation of PKC with
12-0-tertradecanoylphorbol-13-acetate (TPA, another phorbol
ester) led to a decrease in threonine phosphorylation which
correlated with an increase in TER although the subcellular
localization of occludin was not affected [82]. TPA has further
been shown to increase gene transcription of occludin [83]. The
difference in stimulation of PKC by phorbol esters may depend
on additional proteins that are being stimulated including
chimaerins [84], protein kinase D, and/or diacylglycerol kinases
[85]. The catalytic subunit of protein phosphatase 2A (PP2A), a
serine/threonine phosphatase, decreases occludin phosphoryla-
tion and increases TER while okadaic acid, a PP2A inhibitor,
increases occludin phosphorylation and decreases TER [86].
Thus, multiple regulation pathways may provide redundancy to
ensure that occludin localizes correctly to the Tight junction.
The extracellular domains of occludin are shown to function in
localization of occludin to tight junctions and in regulating the
paracellular permeability barrier between cells (Fig. 3). Synthetic
peptides corresponding to a 20-amino acid sequence within the
second extracellular loop of occludin, but not other adherens or
tight junction proteins, increased TER and decreased occludin
levels, as a result of increased protein turnover, and localization to
the tight junction [87]. Photoactivatable crosslinking indicates
that the second extracellular loop of occludin interacts withclaudin and junction adhesion molecule (JAM), and disruption of
these interactions inhibited reformation of tight junctions after
calcium repletion [88]. It should be noted however that the
occludin null mouse does not exhibit deficiencies in barrier
function, but does have an abnormal gastric morphology [89].
Tricellulin a tight junction protein localized at tricellular
junctions, may provide functional redundancy that allows for
intact barrier function in the occludin null mouse [90].
3.1.2. Claudin
The claudin family consists of at least 24 members ranging
from 20 to 27 kDa [5,91] (Fig. 3B). Although claudins do not
share sequence similarity with the occludin family, they also
comprise a tetra-span transmembrane protein [92] with two
extracellular loops [5,91]. Claudins recruit occludin to tight
junctions [92]. With the exception of claudin 12, the
intracellular C-terminal of all other claudin family members
ends in the dipeptide sequence YV [93]. This sequence binds in
the groove of PDZ domain proteins. Inhibition of this domain of
does not affect localization of claudin to tight junctions but
inhibits the association of ZO-1,-2, and -3 proteins [94]; this
interaction will be discussed in the next sub-section.
Claudins form the protein strands of the tight junction that
were observed previously by freeze-fracture electron micros-
copy [95]. When claudins were overexpressed in L fibroblasts
lacking endogenous claudin they formed “paired” strands
within areas of over-lapping cell–cell interactions [92]. These
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forming end-to-end and side-to side interactions. It is thought
that these strands provide a physical barrier between apical and
basolateral membrane; the fence function.
The gate function of the tight junction controls the
paracellular pathway for ion movement in-between cells in an
epithelial layer. Claudins directly regulate the gate function as
paracellular tight junction channels (PTJC) that have biophy-
sical properties similar to those of traditional ion channel
including ion charge selectivity, permeability dependence on
ion concentration, and competition for movement of permeative
molecules [96]. While the majority of channels established by
claudin interactions allow the passage of cations, the passage of
anions has also been observed [5]. Remarkably, changes in the
type of claudin expressed, or single amino acid substitutions in
claudins affect claudin ion selectivity. For example, expression
of claudin 8 in MDCK II cells, which lack endogenous claudin
8, reduced the paracellular movement of mono- and divalent
cations while not affecting the movement of anions or
uncharged solutes [97]. A single substitution of amino acid 65
from a negative to positive charge within the first extracellular
loop of claudin 15 caused an increase in Na2+ permeability.
Mutating three positive charges to negative within the same
region switched the ion selectivity of the claudin channel from
Na2+ to Cl− [98]. Swapping the extracellular loops of claudin 4
and claudin 2 revealed that the first extracellular loop is
sufficient to determine charge selectivity of the ion channel
[99]. Claudin-16, which is expressed solely in the kidney [100],
forms a non-selective cation channel, and mutant claudin-16
results in renal wasting of magnesium and calcium [101].
3.2. Cytoskelatal connectors
3.2.1. ZO proteins
ZO-1, ZO-2, and ZO-3 are members of the MAGUK
(membrane-associated guanylate kinase homologs) family with
binding domains to Adherens and Tight junction proteins in
addition to the actin cytoskeleton (Fig. 4). The MAGUK family
is characterized by their PDZ domain, SH3 domain and
guanylate kinase homologous domain [102]. ZO-1 [103–105]
and ZO-2 [106] have both been shown to bind α-catenin, while
the C-terminus of ZO-3 is sufficient to bind to p120-catenin in
vitro [107]. In addition, in vitro binding assays demonstrated
ZO-1 [108,109] and ZO-2 [106] bind directly to occludin. ZO-1
has been isolated as a homodimer and is proposed to dimerize
through the second PDZ domain [110]. Upon tyrosine phos-
phorylation of occludin, interactions between all ZO proteins
and occludin are reduced [111]. The proline rich C-terminal of
ZO-1 [108] and ZO-3 [112] bind F-actin in co-sedimentation
assays, while ZO-2 does not bind actin [108,113] (Fig. 4). ZO-2
does, however, bind the actin-associated protein 4.1R [114].
ZO-1 can bind ZO-2 or ZO-3 independently, but ZO-2 and ZO-
3 cannot form a binary complex [113]. In addition, in a ZO-1
knock-out/ZO-2 knock-down cell line, exogenous expression of
either ZO-1 or ZO-2 alone could restore claudin localization to
tight junctions as seen by immunofluorescence [115]. The
multiple interactions between the ZO proteins may providedifferent scaffolds and/or connections to the actin-cytoskeleton
(Fig. 4).
ZO-1 has been proposed to be a scaffolding protein between
transmembrane and cytoplasmic proteins, and possibly form a
link between the Adherens and Tight junctions. While ZO-1 can
bind α-catenin, evidence is lacking that ZO-1 can bind actin and
α-catenin simultaneously. In addition, homo-dimerization of
ZO-1 has been proposed to provide a link between the ZO-1/ZO-
2 and ZO-1/ZO-3 complexes, which would link occludin (TJ)
to p120-catenin (AJ) although the interaction between these
two ZO-1 complexes has yet to be investigated [110] (Fig. 4).
It should be noted, however, that the C-terminal of ZO-3,
which binds to p120-catenin, overlaps with the binding region to
N-terminal ZO-3 (Fig. 4). It has been proposed that this switch in
binding could sequester p120-catenin from regulation of RhoA
activity thus affecting actin polymerization [107].
Formation of the Adherens junction through E-cadherin is
associated with the formation and localization of the Tight
junction proteins, particularly ZO-1 [105,116]. Conversely,
expression of mutated ZO-1 in a ZO null cell line significantly
delayed the maturation of the Adherens junction from
“fibroblastic” AJs to “polarized epithelial” AJs [117]. The
region necessary for proper localization of tight junctions has
been mapped to the SH3-U5-GUK-U6 on ZO-1 [118].
Exogenous expression of the N-terminal half of ZO-3 can
delay the localization of E-cadherin, β-catenin, and ZO-1 [112].
Further investigation is necessary to elucidate the connections
amongst ZO proteins during contact formation and maturation.
4. Conclusions
The structure of Adherens and Tight junctions is well
established. While a number of proteins that comprise these
junctions have been presented in this review, additional proteins
are present within these junctions. For example formin, an actin
nucleator binds α-catenin [119] and cortactin , an actin assembly
regulator, binds p120-catenin [120]. In addition, Ankrin-G binds
to the juxtamembrane domain of E-cadherin and recruits beta-2
spectrin to E-cadherin/β-catenin complexes providing another
potential link to the actin cytoskeleton [121]. While this review
focused on the role of conformational states of α-catenin in
regulating actin cytoskeleton reorganization, both formin [119]
and cortactin [122] are necessary for actin reorganization in
mature cell–cell contacts. In addition, Ankrin-G and beta-2
spectrin are required for E-cadherin localization at the plasma
membrane in both cultured cells and mouse embryos [121]. The
proteins presented in this review provide evidence for the for-
mation and maintenance of these junctional complexes. Evidence
is beginning to elucidate the physical connections that are made
between the junctions and the actin-cytoskeleton. Questions re-
main, however, concerning these physical connections, and the
dynamics and regulation of these proposed connections in vivo.
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